Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event

MedExecWomen Third Annual Conference in Boston, June 14, 2022


MedExecWomen, a fast-growing organization dedicated to empowering women in leadership roles in medical device, diagnostics, drug delivery, and digital healthcare, announced today their third annual event will take place on June 14, 2022, in Boston. Attendance is limited to 150 women and in-person only, to foster networking, sharing of strategic content, and collaboration.

Last year's theme centered on "Medical Innovation in a Post-COVID World." During the event, MedExecWomen's Board President said "Innovation in healthcare, particularly post-COVID, requires us to work across industry sectors, alongside clinicians and payers."

For 2022's theme, "Into the Future: New Healthcare Partnerships to Drive Value," female executives and thought leaders will discuss:

The event will close with a keynote by Ginger Graham, former CEO of Guidant Corporation, former faculty member at the Arthur Rock Center for Entrepreneurship at Harvard Business School, and consultant to first-time CEOs in areas of leadership, strategy, board-effectiveness, and organizational building. Registration and the agenda for the conference are available here.

MedExecWomen supports female executives by creating venues to network, refine leadership skills, and develop relevant expertise, striving to:

About MedExecWomen

MedExecWomen is dedicated to empowering women in leadership roles in the medical device, diagnostics, drug delivery, and digital healthcare industries by arming them with relevant strategic skills and robust networks. The organization was co-founded by Laurie Halloran, President & CEO of Halloran Consulting Group, and Maria Shepherd, President & Founder of Medi-Vantage ? medtech executives who believe in fostering relationships and career advancement through insightful meetings and connections.


These press releases may also interest you

at 12:30
New data presented in two separate oral presentations at the European Association for the Study of the Liver's International Liver Congress 2022 (EASL ILC 2022)Following 90 days of dosing, ATI-2173, in combination with tenofovir disoproxil fumarate...

at 11:54
With its ruling today, the U.S. Supreme Court has overturned Roe v. Wade, dismantling the constitutional right to abortion that has stood for nearly 50 years. Roe is overturned at a time when 26 states are poised to ban abortion which will leave 36...

at 11:22
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation between May 12, 2021 and March 11, 2022, both dates inclusive (the "Class Period"), of the important August 5, 2022 lead...

at 09:05
Ionis Pharmaceuticals, Inc. , today...

at 04:05
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients 50% (16 out of 32) of patients maintained HBsAg levels below 100 IU/mL 24 weeks after their last AB-729 dose In the first five patients...

at 00:35
Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the South African Health Products Regulatory Authority (SAHPRA) granted conditional registration to SINOVAC CoronaVac®...



News published on 24 may 2022 at 08:20 and distributed by: